← Open Payments lookup

MEGAN JOHNSON: Open Payments

NPI 1063864783 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,217 in 63 payments from 18 companies in 2025. Trend: 2023 $872 · 2024 $1,143 · 2025 $1,217

Food & beverage: $1,217
CompanyPaymentsAmount
Madrigal Pharmaceuticals17$270
Janssen Biotech, Inc.11$146
Boston Scientific Corporation1$138
ABBVIE INC.4$91
Phathom Pharmaceuticals, Inc.7$69
GENZYME CORPORATION2$62
Regeneron Healthcare Solutions, Inc.3$62
Ipsen Biopharmaceuticals, Inc2$56
Takeda Pharmaceuticals U.S.A., Inc.3$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$45

Products named: REZDIFFRA, AMS 700, TREMFYA, DUPIXENT, RINVOQ, VOQUEZNA, IQIRVO, ENTYVIO.

Industry payments across NE — which companies pay providers there.